Excluding Excise Duty and Other Income, represents Net Revenue
Dishman Carbogen Amcis Ltd revenue growth forecast
Expected growth rate Q1, FY2023:
Forecast
Actual
Including amortisation and stock based compensations
Dishman Carbogen Amcis Ltd EPS growth forecast
EPS estimate Q1, FY2023:
Forecast
Actual
Source: S&P Global Market Intelligence
Day's Low
Day's High
52 Week's Low
52 Week's High
Returns % | |
1 Month Return | + 26.52 % |
3 Month Return | + 46.59 % |
1 Year Return | + 78.89 % |
Market Stats | |
Previous Close | ₹276.48 |
Open | ₹276.10 |
Volume | 21.19L |
Upper Circuit | - |
Lower Circuit | - |
Market Cap | ₹4,443.23Cr |
P/E Ratio | -24.91 |
PEG Ratio | 3.09 |
Market Cap | ₹4,443.23 Cr |
P/B Ratio | 0.91 |
EPS | -9.79 |
Dividend Yield | 0 |
Sector | Pharmaceuticals |
ROE | 0 |
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
---|---|---|---|---|---|---|
NA | ₹4,443.23 Cr | 41.37% | 0.58 | -₹154 Cr | ₹2,615 Cr | |
NA | ₹902.03 Cr | 212.57% | 0.62 | ₹28 Cr | ₹125 Cr | |
NA | ₹15.50 Cr | 15.85% | 0.69 | NA | NA | |
NA | ₹1,163.26 Cr | 14.59% | 0.68 | -₹25 Cr | ₹335 Cr | |
NA | ₹415.00 Cr | 20.66% | 0.57 | NA | NA |
Organisation | Dishman Carbogen Amcis Ltd |
Headquarters | Gujarat |
Industry | Pharmaceuticals |
E-voting on shares | Click here to vote |
Key events for Dishman Carbogen Amcis Ltd
Dishman Carbogen Reports Strong Q3 Results - 19 Nov, 2024
Dishman Carbogen Amcis Reports Q2 Earnings - 14 Nov, 2024
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Revenue Rich
Revenue is up for the last 2 quarters, 525.21 Cr → 795.69 Cr (in ₹), with an average increase of 34.0% per quarter
Profit Spike
Netprofit is up for the last 2 quarters, -77.57 Cr → 33.09 Cr (in ₹), with an average increase of 334.4% per quarter
Retail Holding Up
Retail Investor have increased holdings from 31.16% to 31.28% in Sep 2024 quarter
Price Rise
In the last 1 month, DCAL stock has moved up by 28.8%
FII Holding Up
Foreign Institutions have increased holdings from 8.04% to 8.17% in Sep 2024 quarter
Best in 1 Year
In the last 1 year, DCAL has outperformed top 5 stocks with highest market-cap in Pharmaceuticals
Against Peers
In the last 3 years, Sun Pharmaceuticals Industries Ltd has given 135.8% return, outperforming this stock by 85.6%
Promoter Holding Unchanged
Promoters holdings remained unchanged at 59.32% of holdings in Sep 2024 quarter
MF Holding Down
Mutual Funds have decreased holdings from 1.28% to 1.03% in Sep 2024 quarter
Investors | Holdings % | FY Quarter | 3M change |
---|---|---|---|
Promoter Holdings | 59.32% | 0.00 | |
Foreign Institutions | 8.17% | 1.61 | |
Mutual Funds | 1.03% | ||
Retail Investors | 31.28% | 0.37 | |
Others | 0.2% | 0.00 |
Dishman Carbogen Amcis Ltd in the last 5 years
Lowest (-599.35x)
March 22, 2023
Today (-24.91x)
December 19, 2024
Industry (56.23x)
December 19, 2024
Highest (338.29x)
July 25, 2022
Dishman Carbogen Amcis Ltd’s net profit jumped 180.9% since last year same period to ₹33.09Cr in the Q2 2024-2025. On a quarterly growth basis, Dishman Carbogen Amcis Ltd has generated 142.66% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2019, Dishman Carbogen Amcis Ltd has declared dividend of ₹0.20 - translating a dividend yield of 0.07%.
Read More about DividendsBearish
Neutral
Bullish
Dishman Carbogen Amcis Ltd is currently in a Bullish trading position according to technical analysis indicators.
Dishman Carbogen Amcis Ltd (DCAL) share price today is ₹275.87
Dishman Carbogen Amcis Ltd is listed on NSE
Dishman Carbogen Amcis Ltd is listed on BSE
PE Ratio of Dishman Carbogen Amcis Ltd is -24.91
PE ratio = Dishman Carbogen Amcis Ltd Market price per share / Dishman Carbogen Amcis Ltd Earnings per share
Today’s traded volume of Dishman Carbogen Amcis Ltd(DCAL) is 21.19L.
Today’s market capitalisation of Dishman Carbogen Amcis Ltd(DCAL) is ₹4443.23Cr.
Dishman Carbogen Amcis Ltd(DCAL | Price |
---|---|
52 Week High | ₹307.98 |
52 Week Low | ₹133 |
Dishman Carbogen Amcis Ltd(DCAL) share price is ₹275.87. It is down -10.43% from its 52 Week High price of ₹307.98
Dishman Carbogen Amcis Ltd(DCAL) share price is ₹275.87. It is up 107.42% from its 52 Week Low price of ₹133
Dishman Carbogen Amcis Ltd(DCAL | Returns |
---|---|
1 Day Returns | -0.61% |
1 Month Returns | 26.52% |
3 Month Returns | 46.59% |
1 Year Returns | 78.89% |